Unattributed Code Systems

• http://unstats.un.org/unsd/methods/m49/m49.htm

Copyright Fragment

This fragment is available on en/general_design.html

Copyright and Registered Trademark Uses

• IG © 2023+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.uv.pharm-quality#1.0.0 based on FHIR 5.0.0. Generated 2026-05-10 Links: Table of Contents | QA Report | Version History | CC0 | Propose a change ( src )
• hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )
• Complies with FDA 21 CFR 177.1520 (c) 2.2 (olefin polymers) ( src )
• HL7 FHIR® Pharmaceutical Quality ( src )
• Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions ( src )
• The (c) symbol should NOT be included in this string. It will be added by software when rendering the notation. Full details about licensing, restrictions, warrantees, etc. goes in the more general 'copyright' element. ( src )
• The short copyright declaration (e.g. (c) '2015+ xyz organization' should be sent in the copyrightLabel element. ( src )
• This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html Show Usage * PlanDefinitionType: Bundle/bundle-analytical-procedure-pq-ex1, Bundle/bundle-product-process-validation-pq-ex1, PlanDefinition/plandefinition-drug-pq-ex1-validation-protocol and PlanDefinition/plandefinition-drug-pq-ex2-manufacturing-plan * ObservationValue: PlanDefinition/plandefinition-drug-pq-ex2-manufacturing-plan ( src )

External References

Internal Images

../assets/images/001.svg

FHIR_Data_Pipeline_PQ_Industry_840.png

all-domains-dx-PQ.png

analytical procedures.png

batch_analysis_FHIR_resources.png

compatibility_FHIR_resources.png

container_closure_substance.png

container_closure_system.png

general_properties_substance.png

identification_FHIR_resources.png

impurities_FHIR_resources.png

impurities_substance_resources.png

manufacturing_process_FHIR_resources.png

microbial_attributes_resources.png

organizations_FHIR_resources.png

pharm_industry_timeline.png

process_validation_FHIR_resources.png

product_batch_formula.png

product_batch_info.png

product_description_and_composition.png

product_excipients.png

reference_standards_substance_resources.png

resources overview (complete).png

specification_FHIR_resources.png

stability-pipeline-overview.png

stability_FHIR_resources.png

stability_substance_FHIR_resources.png

substance_analytical_procedures.png

substance_batch_analysis_resources.png

substance_batch_info_resources.png

substance_characterization_resources.png

substance_manufacturing_process_resources.png

substance_process_validation_resources.png

substance_specification_resources.png

tree-filter.png